Pharmapriser ApS: Financial statements 2024
CVR: 36479868
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmapriser ApS (CVR 36479868) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,080 and a net result of DKK -1,860 compared with DKK -36,223 the year before. Equity in the 2024 report amounted to DKK 48,140. The solvency ratio was 91.9%.
- Gross Profit
- DKK -1,080
- Profit/Loss
- DKK -1,860
- Equity
- DKK 48,140
- Total Assets
- DKK 52,381
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1 t. | -2 t. | 48 t. | - |
| 2023 | 10 t. | -8 t. | -36 t. | -74 t. | - |
| 2022 | 87 t. | 17 t. | 17 t. | 105 t. | - |
| 2021 | 78 t. | 24 t. | 19 t. | -41 t. | - |
| 2020 | 44 t. | -4 t. | -3 t. | -59 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 17, 2024, Oscar Thalund-Jørgensen is registered as director of Pharmapriser ApS.
As of July 16, 2024, Oscar Thalund-Jørgensen has stepped down as adm. dir. of Pharmapriser ApS.
Pharmapriser ApS has published its annual report for 2023. Revenue came to DKK 10,263, and the net result was DKK -36,223.
As of February 3, 2024, Christian Frisch is registered as director of Pharmapriser ApS.
As of February 3, 2024, Oscar Thalund-Jørgensen is registered as adm. dir. of Pharmapriser ApS.
As of February 3, 2024, Jacob Frisch has stepped down as director of Pharmapriser ApS.
About Pharmapriser ApS
Pharmapriser ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014. The company is registered under the industry Detailhandel med tøj. The company was previously named MAIN COPENHAGEN ApS. The management consists of Christian Frisch and Oscar Thalund-Jørgensen. The company is owned by JF Consolidated ApS. In 2025, the company reported a gross profit of DKK -6,263 and a net result of DKK -8,073 compared with DKK -1,860 the year before. Equity in the 2025 report amounted to DKK 40,067.